References
- Dietschy JM, Wilson JD. 1970. Regulation of cholesterol metabolism.N. Engl. J. Med., 282: 1179-1183 https://doi.org/10.1056/NEJM197005212822105
- Endo A, and Kuroda M. 1976. Citrinin, an inhibitor of cholesterolsynthesis. J. Antibiotics. 29: 841-843 https://doi.org/10.7164/antibiotics.29.841
- Endo A, Kuroda M, Tsujita Y. 1976. ML-236A, ML-236B andML-236C, new inhibitors of cholestero genesis produced byPenicillium citrinum. J. Antibiot. 29: 1346-1348 https://doi.org/10.7164/antibiotics.29.1346
- Cleeman JI. 2001. Executive Summary of The Third Report ofThe National Cholesterol Education Program(NCEP) ExpertPanel on Detection, Evaluation, And Treatment of High BloodCholesterol In Adults JAMA. 285(19): 2486-2497 https://doi.org/10.1001/jama.285.19.2486
- Freeman DJ, Norrie J, Sttar N, Neely DG, Cobbe SM, Ford I,Isles C, Lorimer AR, Macfarlane PW, McKillop JH, PackardCJ, Shepherd J, Gaw A. 2001. Pravastatin and the developmentof diabetes mellitus: Evidence for a protective treatment effectin the West of Scotland Coronary Prevention Study. Circulation103: 357-362 https://doi.org/10.1161/01.CIR.103.3.357
- Hideyuki H, Harumitsu K, Takeshi K, Akira T, Takashi N. 1986.Structure elucidation of bioactive metabolites of ML-236B(Mevastatin)isolated from dog urine. Chem. Pharm. Bull. 34: 1459-1467 https://doi.org/10.1248/cpb.34.1459
- Hosobuchi M, Testsuya S, Masatoshi A, Jo O, Seigo I, Hiroji Y.1992. Production of ML-236B, and inhibitor of 3-hydroxy-3-methylglutaryl Co A reductase, by Penicillium citrinum :Improvements of strain and culture conditions. Biosci. Biotech.Biochem. 57: 1414-1419 https://doi.org/10.1271/bbb.57.1414
- Kiyoshima K, Takada K, Yamamoto M, Kubo K, Okamoto R,Fukagaway, Ishikura T, Naganawa H, Sawa T, Takeuchi, UmexawaH. 1987. New tylosin anologs produced by mutants ofStreptomyces fradiae. J. Antibiot. 40: 1123-1130 https://doi.org/10.7164/antibiotics.40.1123
- Masahiko H, Ogawa K, Yoshikawa H. 1993. Morphology study inproduction of ML-236B, a precursor of pravastatin sodium, byPenicillium citrinum. J. Ferment. Bioeng. 76: 470-475 https://doi.org/10.1016/0922-338X(93)90243-2
- Miller GL. 1959. Use of dinitrosalicylic acid regent for determinationof reducing Suar. Anal. Chem. 31: 426-428 https://doi.org/10.1021/ac60147a030
- Ni W, Egashira K, Kataoka C, Kitamoto S, Koyanagi M, Inoue S,Takeshima A. 2001. Antiinflammatory and antiarterioscleroticactions of HMG-CoA reductase inhibitor in a rat model ofchronic inhibition of nitric oxide synthesis. Circ. Res. 89: 415-421 https://doi.org/10.1161/hh1701.096614
- Nobufusa S, Hosobuchi N, and Yoshikawa H. 1996. Biochemicaland molecular-approaches for production of Pravastatin, a potentcholesterol-lowering drug. Biotech. Ann. Rev. 2; 373-389 https://doi.org/10.1016/S1387-2656(08)70017-6
- Ongini E, Impagnatiello F, Bonazzi A, Guzzetta M, Govoni M,Monopoli A, Soldato PD, Ignarro LJ. 2004. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhancedantiproliferative and antiinflammatory properties. Proc. Natl.Acad. Sci. 101: 8497-8502 https://doi.org/10.1073/pnas.0401996101
- Serizawa N, Nakagawa K, Hamano K, Tsujita Y, Terahara A,Kuwano H. 1983. Microbial hydroxylation of ML-236B(compactin)and monacolin K. J. Antibiot. 36: 604-607 https://doi.org/10.7164/antibiotics.36.604
- Stryer L.1995. Biochemistry (4th ed). W.H. Freeman and CompanyVirginia, USA, pp. 685-712
- Tobert JA. 1987. New developments in lipid-lowering therapy :the role of inhibiters of hydroxymethyl-glutaryl-coenzyme Areductase, Circulation, 76(3), 534-538 https://doi.org/10.1161/01.CIR.76.3.534
- Tsujita Y, Kuroda M, Shimada T, Tanzawa K, Arai M, Kaneko I,Tanaka M, Masuda H, Tarumi C, Watanabe Y, Fujii S. 1986.CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A reductase : tissue-selective inhibition of sterol synthesisand hypolipidemic effect on various animal species. Biochim.Biophys. Acta. 877: 50-60 https://doi.org/10.1016/0005-2760(86)90117-7
- Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, BaumerAT, Linz W, Bohm M, Nickenig G. 2002. Cellular antioxidanteffects of atrovastatin in vitro and in vivo. Arteriolscler ThrombVasc Biol. 22: 300-305 https://doi.org/10.1161/hq0202.104081
- Witkin EM. 1976. Ultraviolet mutagenesis and inducible DNArepair in Escherichia coli. Bacteriol. Rev. 40: 869-907